Multiple myeloma relapse and drug resistance are addressed with G4 stabilizers that trigger apoptosis by disrupting transcription/replication conflicts.
Redox-cycling compounds generate hydrogen peroxide to selectively eliminate senescent cells beyond Bcl-2 protein targeting.